Long-acting beta2-agonists for chronic obstructive pulmonary disease

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Chronic obstructive pulmonary disease is a common condition and causes the death of millions of people worldwide every year, and the Cochrane Airways Group has already produced several reviews. In October 2013, their collection has been added to with a review of the effects of long-acting beta-agonists. The lead author, Kayleigh Kew from St George’s Hospital in London England, tells us more.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
library
Updated on: October 29, 2013, 12:08

Comments for improvement or correction are welcome.
Email: techsupport@cochrane.org